More articles about Microarrays & Multiplexing

NanoString also beat analyst estimates on the top and bottom lines, and upped its revenue guidance for the year based primarily on collaboration revenues.

Illumina received more orders than expected for NovaSeq in Q2 and sees a big opportunity in the consumer genomics market for its array business and Helix.

The study will combine cognitive assessments with genetic data and survey responses to gain insights into the causes of these two mental health conditions.

A pair of new studies evaluated whole-exome sequencing and other genetic tests in children with epilepsy and in other undiagnosed monogenic disease cases.

With discovery and replication meta-analyses on data for more than 100,000 individuals, researchers identified variants that influence lean mass near five genes.

They demonstrated the applicability of the Simoa platform for nucleic acid detection, and miRNA detection in particular, as Quanterix prepares to launch a new system.

The consumer genomics company will expand its suite of canine genetic tests, and has relocated its headquarters from Boston to Austin.

The presence of these variants also suggested a role for microglia in the development of late-onset Alzheimer's disease, the researchers said.

Using genotyping data for thousands of individuals, investigators identified apparent founder events for dozens of South Asian groups.

Using a combination of genome-wide association and expression quantitative trait loci approaches, investigators uncovered shared and population-specific thyroid cancer risk loci.

The company has not published on its technology, but claims proprietary materials and methods allow it to detect targets in unprocessed biological samples with sub-femtomolar sensitivity.


A small study of prostate cancers from African American and European American men uncovered ancestry-associated splicing with apparent ties to tumor aggressiveness and resistance.

Sweden-based Immunovia is preparing to launch its first diagnostic — a liquid biopsy test for pancreatic cancer — in 2018.

Using array-based miRNA profiles for individuals treated for prostate cancer, researchers identified 37 miRNA with differential expression in cases with recurrence.

Even in schizophrenia cases lacking intellectual disability, investigators found that rare mutations in genes normally resistant to loss-of-function changes were enriched.

The international team says its findings may explain the evolutionary reasons for the maintenance of coronary artery disease in human populations.

Researchers identified truncating, psychosis-related mutations in RBM12 in a family affected by schizophrenia or other psychosis disorders.

Cytox Raises £2.6M

The British genetics company will use the proceeds to support the roll out of its Alzheimer's disease testing service.

Suspicious variants were uncovered through analyses of pediatric cancer survivors from the St. Jude Lifetime Cohort Study and Childhood Cancer Survivor Study.

The company will sell 3 million shares with RW Baird as the sole underwriter of the offering, with a 30-day option to purchase an additional 450,000 shares.

Pages

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.